Kura Oncology
(KURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,362 | -49,525 | -152,631 | -109,845 | -71,243 |
| Depreciation Amortization | -6,383 | -3,036 | -8,571 | -6,052 | -3,378 |
| Other Working Capital | -1,820 | -4,917 | 7,819 | 4,108 | -929 |
| Other Operating Activity | 17,191 | 8,634 | 28,559 | 21,273 | 14,061 |
| Operating Cash Flow | $-91,374 | $-48,844 | $-124,824 | $-90,516 | $-61,489 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -52,070 | -95,253 | 15,725 | -26,486 | -35,065 |
| PPE Investments | -100 | -84 | -168 | -152 | -132 |
| Investing Cash Flow | $-52,170 | $-95,337 | $15,557 | $-26,638 | $-35,197 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 151,409 | 148,369 | 94,783 | 94,092 | 94,008 |
| Financing Cash Flow | $151,409 | $148,369 | $94,783 | $94,092 | $94,008 |
| Beginning Cash Position | 37,318 | 37,318 | 51,802 | 51,802 | 51,802 |
| End Cash Position | 45,183 | 41,506 | 37,318 | 28,740 | 49,124 |
| Net Cash Flow | $7,865 | $4,188 | $-14,484 | $-23,062 | $-2,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,374 | -48,844 | -124,824 | -90,516 | -61,489 |
| Capital Expenditure | -100 | -84 | -168 | -152 | -132 |
| Free Cash Flow | -91,474 | -48,928 | -124,992 | -90,668 | -61,621 |